"Signature Disease" Status Doesn't Change Analysis

Law360, New York (February 8, 2008, 12:00 AM EST) -- The federal court charged with overseeing the Fosamax multidistrict products liability litigation recently declined plaintiffs' request to certify three state-specific classes seeking recovery for medical monitoring.

The putative representative claimants had failed to satisfy the requirements for class certification under Rule 23, according to Judge John F. Keenan of the U.S. District Court for the Southern District of New York, because the proposed class definitions were irreparably overbroad and because too many individual questions of fact particular to each class member's claim rendered class treatment an...
To view the full article, register now.